The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma. (Q53222639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Josef Pfeilschifter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Paul Gutwein

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

30 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1713-1723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Pax-2 expression in adult renal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Rescue of defective branching nephrogenesis in renal-coloboma syndrome by the caspase inhibitor, Z-VAD-fmk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

A PANorama of PAX genes in cancer and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

PAX2 suppresses apoptosis in renal collecting duct cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

The ADAMs: signalling scissors in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

ADAMs in cancer cell proliferation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Met, metastasis, motility and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Molecular basis of the VHL hereditary cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Kidney cancer: opportunity for disease specific targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Regulation of cadherin-mediated adhesion in morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

The disintegrin-metalloproteinases ADAM 10, 12 and 17 are upregulated in invading peripheral tumor cells of basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR195

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGR195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21880579%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference